Articles:

K Venkatakrishnan, J Schmider, JS Harmatz, BL Ehrenberg, LL von Moltke, JA Graf, P Mertzanis, KE Corbett, MC Rodriguez, RI Shader, and DJ Greenblatt

Relative contribution of CYP3A to amitriptyline clearance in humans: in vitro and in vivo studies
J Clin Pharmacol 2001 41: 1043. [Abstract] [PDF]  

T Kobayashi and Y Homma

Effects of low-dose pravastatin on plasma levels of lipids and apolipoproteins in Japanese type II hyperlipoproteinemic subjects with apolipoprotein E phenotype E3/2, E3/3, and E4/3
J Clin Pharmacol 2001 41: 1055. [Abstract] [PDF]  

SR Penzak, MW Jann, JA Cold, YY Hon, HD Desai, and BJ Gurley

Seville (sour) orange juice: synephrine content and cardiovascular effects in normotensive adults
J Clin Pharmacol 2001 41: 1059. [Abstract] [PDF]  

T Wells, R Rippley, R Hogg, A Sakarcan, D Blowey, P Walson, B Vogt, A Delucchi, MW Lo, E Hand, D Panebianco, W Shaw, and S Shahinfar

The pharmacokinetics of enalapril in children and infants with hypertension
J Clin Pharmacol 2001 41: 1064. [Abstract] [PDF]  

E Zecca, P Papacci, L Maggio, F Gallini, S Elia, G De Rosa, and C Romagnoli

Cardiac adverse effects of early dexamethasone treatment in preterm infants: a randomized clinical trial
J Clin Pharmacol 2001 41: 1075. [Abstract] [PDF]  

JV Gobburu, V Tammara, L Lesko, SS Jhee, JJ Sramek, NR Cutler, and R Yuan

Pharmacokinetic-pharmacodynamic modeling of rivastigmine, a cholinesterase inhibitor, in patients with Alzheimer's disease
J Clin Pharmacol 2001 41: 1082. [Abstract] [PDF]  

F Aweeka, C Trapnell, M Chernoff, A Jayewardene, J Spritzler, SE Bellibas, P Lizak, and J Jacobson

Pharmacokinetics and pharmacodynamics of thalidomide in HIV patients treated for oral aphthous ulcers: ACTG protocol 251. AIDS Clinical Trials Group
J Clin Pharmacol 2001 41: 1091. [Abstract] [PDF]  

KH Moore, LM Cass, N Dallow, TC Hardman, A Jones, M Boyce, and WT Prince

Pharmacokinetics and tolerability of GW420867X, a nonnucleoside reverse transcriptase inhibitor, following single escalating doses in healthy male volunteers
J Clin Pharmacol 2001 41: 1098. [Abstract] [PDF]  

NG Agrawal, AG Porras, CZ Matthews, EJ Woolf, JL Miller, S Mukhopadhyay, DC Neu, and KM Gottesdiener

Dose proportionality of oral etoricoxib, a highly selective cyclooxygenase-2 inhibitor, in healthy volunteers
J Clin Pharmacol 2001 41: 1106. [Abstract] [PDF]  

A Karim, A Laurent, ME Slater, ME Kuss, J Qian, SL Crosby-Sessoms, and RC Hubbard

A pharmacokinetic study of intramuscular (i.m.) parecoxib sodium in normal subjects
J Clin Pharmacol 2001 41: 1111. [Abstract] [PDF]  

JI Schwartz, NG Agrawal, PH Wong, KA Bachmann, AG Porras, JL Miller, DL Ebel, MR Sack, GB Holmes, JS Redfern, and BJ Gertz

Lack of pharmacokinetic interaction between rofecoxib and methotrexate in rheumatoid arthritis patients
J Clin Pharmacol 2001 41: 1120. [Abstract] [PDF]  

H Zhou, A Horowitz, PC Ledford, M Hubert, S Appel-Dingemanse, S Osborne, and JF McLeod

The effects of tegaserod (HTF 919) on the pharmacokinetics and pharmacodynamics of digoxin in healthy subjects
J Clin Pharmacol 2001 41: 1131. [Abstract] [PDF]  

To see an article, click its [Full Text] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.